Columbia, MD, USA - Shimadzu Scientific Instruments will host new product showcases and poster presentations, as well as a hospitality suite and press conference, as part of its exhibition plans for the 58th ASMS Conference on Mass Spectrometry (May 23-27, Salt Palace Convention Center, Salt Lake City, Booth 86).
In addition to showcasing its full range of instruments, from MALDI and LCMS mass spectrometers to GCMS and a series of front-end LC systems, Shimadzu will highlight the following new products:
Additionally, Shimadzu and Johns Hopkins Center for Biomarker Discovery have partnered to develop new glycoproteomics technologies. The collaboration will focus on developing immuno-MS assays to identify prostate-specific glycoproteins and their glycosylation patterns toward improved blood tests for early stage prostate cancer.
Shimadzu will also present 37 posters in a variety of sessions, including Biomarker Discovery, Metabolemics, Glycoproteins, Proteomics, Small Molecule Analysis, Environmental Analysis and Natural Products. For more information, visit www.ssi.shimadzu.com/ASMS
About Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $2 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. The Analytical Instruments division is one of the world's largest manufacturers of analytical instrumentation and environmental monitoring equipment. In 1975, SSI corporate headquarters was established in Columbia, Md., to provide analytical solutions to laboratories in North, Central and parts of South America. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit www.ssi.shimadzu.com for more information.